Spring House, PA, United States of America

Christopher M Flores

This inventor holds 29 USPTO granted patents and 3 published patent applications, plus 7 CIPO patents and 14 EPO patents, primarily in Calcium Channel Blockers. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica. Active years: 2008-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher M Flores. Retrieved from https://idiyas.com/inventor/christopher-m-flores

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 3)

% Patents Active = 51.7

CIPO Patents = 7

EPO Patents = 14 (Patent Applications = 23)

Average Co-Inventor Count = 5.6

ph-index = 9

Forward Citations = 158(Granted Patents)

Location History:

Spring House, PA (US) (2012 - 2014)
Lansdale, NJ (US) (2014)
Lansdale, PA (US) (2008 - 2020)

Company Filing History:

28 out of 2,101

Janssen Pharmaceutica Nv

patents

1 out of 32

Janssen Pharmaceutica

patents

Years Active: 2008-2020

Loading Chart...

Areas of Expertise:

Calcium Channel Blockers

TRPM8 Modulators

Monoacylglycerol Lipase Inhibitors

Pyrazoles

Sulfonamides

Menthol Receptor Antagonists

Metabolic Diseases

Azetidinyl Diamides

Heteroaromatic Compounds

C-Fms Kinase Inhibitors

Polypeptide Complex

Screening Methods

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10653673 - Substituted imidazoles as N-type calcium channel blockers (2020-05-19),

2. 9974775 - Substituted imidazoles as N-type calcium channel blockers (2018-05-22),

3. 9434711 - Sulfonamides as TRPM8 modulators (2016-09-06),

4. 9434693 - Substituted pyrazoles as N-type calcium channel blockers (2016-09-06),

5. 9375430 - Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders (2016-06-28),

6. 9096521 - Cold menthol receptor antagonists (2015-08-04),

7. 9090639 - Cold menthol receptor-1 antagonists (2015-07-28),

8. 8987247 - Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders (2015-03-24),

9. 8962607 - Azetidinyl diamides as monoacylglycerol lipase inhibitors (2015-02-24),

10. 8901314 - Substituted pyrazoles as N-type calcium channel blockers (2014-12-02),

11. 8853418 - Cyclopentylpyrazoles as N-type calcium channel blockers (2014-10-07),

12. 8809327 - Sulfonamides as TRPM8 modulators (2014-08-19),

13. 8729064 - Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors (2014-05-20),

14. 8697683 - Azetidinyl diamides as monoacylglycerol lipase inhibitors (2014-04-15),

15. 8653099 - Cold menthol receptor antagonists (2014-02-18),

Title: The Innovative Journey of Christopher M Flores

Introduction: Christopher M Flores, a talented inventor hailing from Spring House, PA (US), has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Christopher M Flores holds several patents in the field of renewable energy technologies, including a solar panel efficiency optimization system and a wind turbine blade design for increased energy production.

Career Highlights: With a background in mechanical engineering, Christopher M Flores has worked for leading renewable energy companies, where he honed his skills in developing sustainable solutions. His passion for innovation has led to the creation of patents that have revolutionized the renewable energy sector.

Collaborations: Throughout his career, Christopher M Flores has collaborated with top researchers and engineers in the field of renewable energy, fostering a culture of innovation and creativity. His collaborative efforts have resulted in cutting-edge technologies that are shaping the future of sustainable energy.

Conclusion: Christopher M Flores stands as a beacon of innovation in the realm of renewable energy, with a remarkable track record of patents and inventions that are driving positive change in the world. His dedication to creating sustainable solutions underscores his commitment to a greener, more sustainable future.

Profile summary based on public USPTO records.